Russ has over 30 years of cross-sector experience as a venture capital and private equity investor. He spent 16 years at 3i Group during a period when it grew from a UK company, to a global investor spanning continental Europe, US and Asia. Highlights included investments in Sophos (LON:SOPH), Queensgate Instruments (acquired by SDL $210m), Content Technologies (acquired by Baltimore $1bn) and Oxford Asymmetry (acquired by Evotec £316m). He subsequently joined Scottish Equity Partners to launch and head up its London office. Successful investments included Searchspace (acquired by Warburg Pincus $140m) and Zeus Technology (acquired by Riverbed $140m). More recently, Russ was CEO of Touchstone Innovations plc, helping build Touchstone into an internationally recognised leader in providing patient capital to high growth businesses.
Russ is currently a Non-Executive Director on the board of British Patient Capital Ltd, a subsidiary of the British Business Bank, and Circassia Pharmaceuticals plc.